Category: Include on Menu

  • International Seaways shares gain as record Q2 profit beats expectations

    International Seaways shares gain as record Q2 profit beats expectations

    International Seaways, Inc. (NYSE:INSW) shares rose 2.26% on Monday after the tanker operator delivered second-quarter results comfortably ahead of Wall Street forecasts, supported by substantially stronger shipping rates and record profitability. Adjusted earnings reached $5.91 per share, exceeding the analyst consensus estimate of $5.52 by $0.39. Quarterly revenue surged to $467.29 million, well above the…

  • Sionna Therapeutics shares collapse 92% after cystic fibrosis trial misses key endpoint

    Sionna Therapeutics shares collapse 92% after cystic fibrosis trial misses key endpoint

    Sionna Therapeutics (NASDAQ:SION) shares plunged 92% on Monday after the biotechnology company reported disappointing results from its Phase 2a proof-of-concept study of SION-719 in cystic fibrosis. The PreciSION CF trial failed to achieve its key activity endpoint, which measured the reduction in sweat chloride when SION-719 was administered alongside the standard-of-care treatment Trikafta. The study…

  • Camtek stock advances as record Q2 revenue and upbeat guidance impress investors

    Camtek stock advances as record Q2 revenue and upbeat guidance impress investors

    Camtek Ltd. (NASDAQ:CAMT) shares climbed 3.64% in pre-market trading on Monday after the semiconductor equipment specialist reported better-than-expected second-quarter results and outlined expectations for a significant acceleration in growth during the remainder of 2026. The company generated adjusted earnings of $0.78 per share, coming in $0.03 above the Wall Street consensus forecast of $0.75. Revenue…

  • AbCellera shares surge 22% after ABCL635 delivers positive Phase 2 results

    AbCellera shares surge 22% after ABCL635 delivers positive Phase 2 results

    AbCellera (NASDAQ:ABCL) shares jumped 22% on Monday after the biotechnology company announced positive topline results from a Phase 2 clinical trial evaluating ABCL635 as a potential treatment for moderate-to-severe vasomotor symptoms associated with menopause. The study achieved its primary efficacy endpoints, demonstrating statistically significant reductions in both the frequency and severity of moderate-to-severe vasomotor symptoms…

  • Powerfleet shares tumble 17% as revenue miss and weaker guidance overshadow earnings beat

    Powerfleet shares tumble 17% as revenue miss and weaker guidance overshadow earnings beat

    Powerfleet Inc. (NASDAQ:AIOT) shares dropped 17.69% in pre-market trading on Monday after the company reported mixed fiscal first-quarter 2027 results, with earnings coming in ahead of expectations but revenue falling short of Wall Street forecasts. The connected-operations technology company posted an adjusted loss of $0.01 per share, slightly better than the analyst consensus for a…

  • SpaceX retail investors become net sellers for first time since IPO

    SpaceX retail investors become net sellers for first time since IPO

    Retail investors turned into net sellers of SpaceX (NASDAQ:SPCX) shares on Friday for the first time since Elon Musk’s space company completed its initial public offering in June, according to data from Vanda Research. Individual traders sold a net $4.5 million of SpaceX shares on August 7, representing the first day of negative retail flows…

  • Entera Bio shares slip as Q2 loss comes in wider than expected

    Entera Bio shares slip as Q2 loss comes in wider than expected

    Entera Bio Ltd. (NASDAQ:ENTX) shares fell 1.05% in pre-market trading after the clinical-stage biotechnology company reported a larger-than-expected second-quarter loss as spending increased ahead of a pivotal trial for its oral osteoporosis treatment EB613. The company posted a loss of $0.14 per share for the quarter, compared with the analyst estimate for a loss of…

  • Dole shares fall 5% after Q2 earnings and revenue miss expectations

    Dole shares fall 5% after Q2 earnings and revenue miss expectations

    Dole plc (NYSE:DOLE) shares dropped 5.35% in pre-market trading on Monday after the fresh produce group reported second-quarter earnings and revenue below Wall Street forecasts, as higher fruit sourcing and transportation costs weighed on profitability. For the quarter ended June 30, 2026, Dole recorded adjusted earnings per share of $0.46, falling short of the analyst…

  • National Energy Services Reunited shares jump 10% after Q2 earnings beat

    National Energy Services Reunited shares jump 10% after Q2 earnings beat

    National Energy Services Reunited Corp. (NASDAQ:NESR) shares surged 10.27% in pre-market trading on Monday after the energy services company delivered second-quarter results comfortably ahead of Wall Street expectations. Adjusted earnings per share reached $0.44, beating the analyst consensus of $0.34 by $0.10, while revenue also came in significantly above market forecasts. Quarterly revenue climbed to…

  • Dick’s Sporting Goods shares rise after Wells Fargo upgrade

    Dick’s Sporting Goods shares rise after Wells Fargo upgrade

    Dick’s Sporting Goods (NASDAQ:DNTH) shares gained 2.4% in pre-market trading on Monday after Wells Fargo upgraded the sporting goods retailer to Overweight from Equal Weight and increased its price target to $240 from $220. The broker pointed to recent weakness in the share price as an attractive entry opportunity for investors, signalling greater confidence in…